Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 21487117)

Published in Eur Heart J on April 12, 2011

Authors

Josep Redon1, Michael H Olsen, Richard S Cooper, Oscar Zurriaga, Miguel A Martinez-Beneito, Stephane Laurent, Renata Cifkova, Antonio Coca, Guiseppe Mancia

Author Affiliations

1: Hypertension Clinic, Hospital Clinico, University of Valencia (INCLIVA) and CIBERObn Institute of Health Carlos III, Avda Blasco Ibañez, 17, 46010 Madrid, Spain. josep.redon@uv.es

Associated clinical trials:

ROOD's Sensory Motor Training in Sub-acute Stroke | NCT04173481

Multisensory Stimulation Exercises And Task Oriented Exercises On Upper Limb Function In Post Stroke Patients. | NCT04807426

Articles citing this

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

Sex differences in stroke. J Cereb Blood Flow Metab (2012) 1.21

Trends in incidence of hypertension in Chinese adults, 1991-2009: the China Health and Nutrition Survey. Int J Cardiol (2014) 1.09

Changes in stroke epidemiology, prevention, and treatment. Circulation (2011) 1.04

Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology (2015) 1.02

Association between Arsenic Exposure from Drinking Water and Longitudinal Change in Blood Pressure among HEALS Cohort Participants. Environ Health Perspect (2015) 0.93

How are treatment decisions made about artificial nutrition for individuals at risk of lacking capacity? A systematic literature review. PLoS One (2013) 0.88

A literature review of indirect costs associated with stroke. J Stroke Cerebrovasc Dis (2014) 0.88

The 1027th target candidate in stroke: Will NADPH oxidase hold up? Exp Transl Stroke Med (2012) 0.87

Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China. BMJ Open (2014) 0.87

Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health (2013) 0.85

Eating and drinking interventions for people at risk of lacking decision-making capacity: who decides and how? BMC Med Ethics (2015) 0.82

Elevated hypertension risk for African-origin populations in biracial societies: modeling the Epidemiologic Transition Study. J Hypertens (2015) 0.80

New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon? Curr Hypertens Rep (2015) 0.78

Long-Term Outcomes after Stroke in Elderly Patients with Atrial Fibrillation: A Hospital-Based Follow-Up Study in China. Front Aging Neurosci (2016) 0.77

Trends in Incidence of Stroke and Transition of Stroke Subtypes in Rural Tianjin China: A Population-Based Study from 1992 to 2012. PLoS One (2015) 0.76

Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy. Int J Mol Sci (2015) 0.76

Trends in major risk factors and mortality from main non-communicable diseases in Lithuania, 1985-2013. BMC Public Health (2016) 0.76

Twenty years trends in mortality rates from stroke in Klaipeda. Brain Behav (2016) 0.75

Effects of alteplase in the treatment of acute ischemic stroke. Int J Gen Med (2012) 0.75

Longitudinal changes in functioning and disability in patients with disorders of consciousness: the importance of environmental factors. Int J Environ Res Public Health (2015) 0.75

Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke. Stroke Res Treat (2014) 0.75

Effect of age on long-term outcomes after stroke with atrial fibrillation: a hospital-based follow-up study in China. Oncotarget (2017) 0.75

Articles by these authors

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17

Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet (2007) 14.99

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J (2012) 13.74

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol (2004) 9.43

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet (2006) 7.89

Admixture mapping for hypertension loci with genome-scan markers. Nat Genet (2005) 6.78

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J (2007) 5.92

Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension (2003) 5.63

ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87

Physical activity does not influence obesity risk: time to clarify the public health message. Int J Epidemiol (2013) 4.71

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59

Association mapping, using a mixture model for complex traits. Genet Epidemiol (2002) 3.95

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78

Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43

From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A (2008) 3.39

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol (2005) 3.27

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13

Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension (2005) 3.07

A unified association analysis approach for family and unrelated samples correcting for stratification. Am J Hum Genet (2008) 3.00

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens (2003) 2.76

Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens (2009) 2.71

Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens (2012) 2.71

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70

Neighborhood characteristics and hypertension. Epidemiology (2008) 2.70

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension (2005) 2.69

Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant (2009) 2.69

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62

The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet (2007) 2.35

Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet (2006) 2.34

Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol. Am J Hum Genet (2007) 2.28

Linkage analysis of a complex disease through use of admixed populations. Am J Hum Genet (2004) 2.21

Oxysterols direct immune cell migration via EBI2. Nature (2011) 2.19

Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension (2007) 2.17

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis (2012) 2.10

Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol (2010) 1.99

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98

Genetics. The science and business of genetic ancestry testing. Science (2007) 1.95

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol (2010) 1.92

Genome-wide association of anthropometric traits in African- and African-derived populations. Hum Mol Genet (2010) 1.90

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89

A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet (2002) 1.87

Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87

Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation (2005) 1.84

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ (2013) 1.81

Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet (2011) 1.77

Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76

2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press (2007) 1.76

Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens (2004) 1.69

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens (2002) 1.69

Eligibility for renal denervation: experience at 11 European expert centers. Hypertension (2014) 1.68

Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67

Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens (2006) 1.64

Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry. J Hypertens (2007) 1.62

Association between blood pressure and resting energy expenditure independent of body size. Hypertension (2004) 1.62

Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens (2002) 1.62

Bayesian factor analysis to calculate a deprivation index and its uncertainty. Epidemiology (2011) 1.61

Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens (2007) 1.60

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)]. G Ital Cardiol (Rome) (2013) 1.57

Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study. Hypertension (2012) 1.55

Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55

Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55

Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension (2012) 1.54

Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium. Hum Mol Genet (2011) 1.54

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens (2004) 1.53

The Nigerian antihypertensive adherence trial: a community-based randomized trial. J Hypertens (2013) 1.52

European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med (2012) 1.51

Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens (2009) 1.50

Interrogating local population structure for fine mapping in genome-wide association studies. Bioinformatics (2010) 1.48

Cardiovascular morbidity and mortality and left ventricular geometric patterns in hypertensive patients treated in primary care. Rev Esp Cardiol (2009) 1.48

Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47